Ischemic Heart Disease

Ischemic heart disease (IHD) refers to a group of clinical syndromes characterised by myocardial ischemia, or an imbalance in the supply and demand for myocardial blood. Because the fundamental pathophysiologic defect in the ischemic myocardium is insufficient perfusion, ischemia is associated not only with insufficient oxygen supply, but also with decreased nutrient availability and insufficient removal of metabolic endproducts. The effects of oxygen deprivation cannot be separated from the effects of impaired metabolite washout in myocardial ischemia. The deleterious consequences to the myocardium are generally less prominent in conditions associated with isolated hypoxemia and preserved perfusion (such as cyanotic congenital heart disease, severe anaemia, or advanced lung disease), emphasising the importance of metabolite removal and supply with metabolic substrates in the pathogenesis of ischemic injury.

    Related Conference of Ischemic Heart Disease

    March 11-12, 2024

    13th World Heart Congress

    Paris, France
    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    October 30-31, 2024

    7th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada

    Ischemic Heart Disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in